Though the practice of acupuncture predates current understanding of physiology by several millennia, it often provides measureable improvements in health outcomes, particularly in the area of chronic pain. Now, in a study reported in the journal Brain, a team of investigators based at the Athinoula A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital (MGH) sheds new light on the question of how.
“Acupuncture is a medical therapy that originated in China several thousand years ago,” said Vitaly Napadow, PhD, director of the Center for Integrative Pain Neuroimaging at the Martinos Center and senior author of the Brain paper. “But despite its long history, the intervention itself – particularly when coupled with electrical stimulation – has significant similarities to many conventional therapies, such as transcutaneous electrical nerve stimulation. A large body of clinical research exploring acupuncture for chronic pain disorders has demonstrated that it may be marginally better than a placebo procedure in reducing pain ratings. But questions still remain: How exactly does acupuncture work? Is it any better at improving objective outcomes for chronic pain?”
To get to the root of these questions, Napadow and colleagues performed a sham-controlled acupuncture neuroimaging study of carpal tunnel syndrome (CTS), a neuropathic pain disorder. Few chronic pain disorders have established biomarkers or measureable treatment outcomes. However, in CTS measurements taken at the wrist of the speed at which signals are transmitted along the median nerve are a well known and accepted biomarker. In addition, studies by Napadow and others have shown that the brain – particularly the primary somatosensory cortex, which receives signals related to the sense of touch – is remapped in CTS. Specifically, brain cells that usually respond to touch signals from specific fingers start to respond to signals from multiple fingers, which provides another measureable outcome.
Using functional magnetic resonance imaging (fMRI) taken before and after several months of therapy in three different groups of CTS patients – one receiving electro-acupuncture at the affected hand, one receiving electro-acupuncture at the ankle opposite the affected hand, and the other receiving sham electro-acupuncture with placebo needles near the affected hand – the researchers found that both real and sham acupuncture improved patient-reported CTS symptoms. However, there were notable differences in physiologic measures. Real acupuncture at the affected hand led to measurable improvements in outcomes both at the affected wrist and in the brain, while acupuncture at the opposite ankle produced improvement at the wrist only. Brain remapping immediately after real acupuncture was linked to long-term improvement in CTS symptoms. No physiologic improvements resulted from sham acupuncture.
Even after years of clinical research, controversy continues as to whether acupuncture works primarily by the placebo effect, especially given the slight differences between the efficacy of real and sham acupuncture. The findings of the Brain study help to address this question. Sham acupuncture may produce a stronger placebo effect than a pill because it sends inputs to the brain via skin receptors and is coupled with a specific ritual. But the symptom improvement produced by sham treatment for conditions like CTS also might derive from entirely different mechanisms than those elicited by real acupuncture, the mechanisms of which may more specifically target CTS pathophysiology.
“Sham acupuncture may ‘work’ by modulating known placebo circuitry in the brain,” Napadow said. “In contrast, real acupuncture may improve CTS symptoms by rewiring the primary somatosensory cortex, in addition to modulating local blood flow to the peripheral nerve in the wrist. In other words, both peripheral and central neurophysiological changes in CTS may be halted or even reversed by electro-acupuncture interventions that provide more prolonged and regulated input to the brain – something that future, longer-term neuroimaging studies should explore.”
Napadow and colleagues plan to follow up the Brain study with further research linking objective/physiological and subjective/psychological outcomes for acupuncture-produced pain relief. Better understanding of how acupuncture works to relieve pain ultimately will enable them and others to optimize the therapy to provide effective, non-pharmacological care for chronic pain patients.
Yumi Maeda and Hyungjun Kim of the Martinos Center are co-lead authors of the Brain paper. Additional co-authors are Jieun Kim, Stephen Cina, Jessica Gerber, Pia Mezzacappa, Alexandra Libby and Ishtiaq Mawla, Martinos Center; Norman Kettner, Logan University, Chesterfield, Missouri; Cristina Malatesta, Clair McManus, Rebecca Ong-Sutherland and Leslie Morse, Spaulding Rehabilitation Hospital; Ted Kaptchuk, Beth Israel Deaconess Medical Center, and Joseph Audette, Harvard Vanguard Medical Associates. The study was supported by the National Center for Complementary and Integrative Health; National Institutes of Health grants R01 AT004714, R01 AT004714-02S1, P01 AT002048 and K24 AT004095; Korea Institute of Oriental Medicine grant C16210; and National Center for Research Resources grants P41 RR14075, S10 RR021110 and S10 RR023043.
Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The MGH Research Institute conducts the largest hospital-based research program in the nation, with an annual research budget of more than $800 million and major research centers in HIV/AIDS, cardiovascular research, cancer, computational and integrative biology, cutaneous biology, human genetics, medical imaging, neurodegenerative disorders, regenerative medicine, reproductive biology, systems biology, photomedicine and transplantation biology. The MGH topped the 2015 Nature Index list of health care organizations publishing in leading scientific journals and earned the prestigious 2015 Foster G. McGaw Prize for Excellence in Community Service. In August 2016 the MGH was once again named to the Honor Roll in the U.S. News & World Report list of "America’s Best Hospitals."
Press ReleaseMar | 2 | 2017